Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Jon Faldasz: Why Aren’t We Better at Achieving Therapeutic Warfarin Control?
Jon Faldasz/LinkedIn
Nov 21, 2025, 08:55

Jon Faldasz: Why Aren’t We Better at Achieving Therapeutic Warfarin Control?

Jon Faldasz, Senior Director of Product and Customer Experience at InsightRX, posted on LinkedIn:

”Ok I know warfarin is the stinky kid in the corner, but it’s not going anywhere. So why aren’t we better at achieving time in therapeutic range?

Could it be:
– We think that 40% time in range is “good enough”? (data argues otherwise)
– Low warfarin use means we think this problem isn’t significant (patients would argue otherwise)
– We think that the problem is unsolvable? (Anticoagulation specialists argue otherwise)

I would love to get some comments to bring with me to the Anticoagulation Forum Stewardship Summit. Don’t make me call you out, people.”

Jon Faldasz

Stay updated with Hemostasis Today.

Anticoagulation Anticoagulation Forum Health Hematology Hemostasis Hemostasis Today Jon Faldasz Medicine thrombosis Warfarin
NewsFeed